HOME >> BIOLOGY >> NEWS
Study shows benefits to newborns from federal ban on insecticides

A federal ban on two insecticides has resulted in a significant reduction in their impact on newborns' birth weight and length, according to a new study funded by the National Institute of Environmental Health Sciences of the National Institutes of Health, the U.S. Environmental Protection Agency, and other private foundations.

The results of the study - the first one to demonstrate the benefits of the ban during pregnancy in human subjects - will be published in Environmental Health Perspectives, the monthly peer-reviewed journal of the NIEHS. It is now available online at http://ehp.niehs.nih.gov.

The study, released by the Columbia Center for Children's Environmental Health, part of the Mailman School of Public Health at Columbia University, measured the impact on fetal growth of two insecticides - chlorpyrifos and diazinon - whose use in households was banned by the federal government starting in 2000. The insecticides had been among the most commonly-used agents for residential pest control.

In the study, researchers measured the levels of the two insecticides in blood drawn from the umbilical cords after delivery, both before and after the ban, and correlated those levels with the babies' birth weight and length. All blood samples were frozen and stored at -70 degrees Centigrade in order to ensure the stability of the pesticides. Subsequent analyses were performed on frozen samples at three different times -- spring 2001, summer 2002 and fall 2002.

They found that prior to January 2001, newborns with combined insecticide exposures in the highest 26th percentile had birth weights averaging almost 200 grams (almost half a pound) less than infants with no detectable pesticide levels. The researchers also noted a highly significant inverse association between the combined exposures and newborn birth length. However, when they looked at the relationship between insecti
'"/>

Contact: John Peterson
peterso4@niehs.nih.gov
919-541-7860
NIH/National Institute of Environmental Health Sciences
24-Mar-2004


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... 15, 2019 , ... Serialization deadlines in the US and ... and aggregation becomes fully applied in the United States in 2023, pharmaceutical companies ... Until now, most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal ...
(Date:8/14/2019)... ... 2019 , ... Representatives with MyBioGate announced that China Focus@Biotech Week will be ... help innovative projects connect with Chinese pharma and investors in healthcare innovation,” said Miao ... explain that as a part of Biotech Week Boston – the annual biotech festival ...
(Date:8/6/2019)... ... August 06, 2019 , ... A ... system that could have far-reaching implications for personalized medicine, especially when seeking treatments ... is able to predict which stem cell donors and manipulation methods might yield ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... ... recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical ... latest report, Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel is ...
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, ... Where Beasts Meet Biotech. The film focuses on regenerative veterinary medicine as a ... Pharm was recently included in the Brentwood and Pacific Palisades International Film ...
(Date:6/12/2019)... N.J. (PRWEB) , ... June 12, 2019 , ... ... custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and ... Shanghai Zillion has been signed. The agreement will grant exclusive rights for Zillion ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the ... national leader in opioid treatment, announced today they are partnering to combat the ... recently deployed its virtual care platform at the Mayo Clinic to drive shared ...
Breaking Biology Technology:
Cached News: